| 000 | 01356 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515183543.0 | ||
| 264 | 0 | _c20091211 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1875-9114 | ||
| 024 | 7 |
_a10.1592/phco.29.9.1089 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDobesh, Paul P | |
| 245 | 0 | 0 |
_aPharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitor. _h[electronic resource] |
| 260 |
_bPharmacotherapy _cSep 2009 |
||
| 300 |
_a1089-102 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAbsorption |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPiperazines _xchemistry |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xchemistry |
| 650 | 0 | 4 | _aPrasugrel Hydrochloride |
| 650 | 0 | 4 | _aProdrugs |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 |
_aPyridines _xchemistry |
| 650 | 0 | 4 |
_aThiophenes _xchemistry |
| 650 | 0 | 4 | _aTime Factors |
| 773 | 0 |
_tPharmacotherapy _gvol. 29 _gno. 9 _gp. 1089-102 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1592/phco.29.9.1089 _zAvailable from publisher's website |
| 999 |
_c19100241 _d19100241 |
||